We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.50 | 3.86% | 228.50 | 228.50 | 231.00 | 234.00 | 221.00 | 222.00 | 323,586 | 16:35:07 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medicinal Chems,botanicl Pds | 139.99M | -45.16M | -0.4676 | -4.90 | 221.17M |
TIDMOXB
RNS Number : 4792K
Oxford Biomedica PLC
04 January 2021
For Immediate Release 04 January 2021
OXFORD BIOMEDICA PLC
BLOCK LISTING RETURN
Hot Features
Premium
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Employee Share Option Scheme
--------------------------------------
Period of return: From: 1 July 2020 To: 31 December 2020
------------------------ ------------- ---- -----------------
Balance of unallotted securities under scheme(s) from previous return: 173,014
--------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 200,000
--------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period (see
LR3.5.7G): 159,816
--------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 213,198
--------------------------------------
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Long Term Incentive Plan
-------------------------------------
Period of return: From: 1 July 2020 To: 31 December 2020
------------------------ ------------ ---- -----------------
Balance of unallotted securities under scheme(s) from previous return: 211,739
-------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the NIL
date of the last
return (if any increase has been applied for):
-------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period (see
LR3.5.7G): 31,979
-------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 179,760
-------------------------------------
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Deferred Bonus Plan
-------------------------------------
Period of return: From: 1 July 2020 To: 31 December 2020
------------------------ ------------ ---- -----------------
Balance of unallotted securities under scheme(s) from previous return: 85,644
-------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the
date of the last
return (if any increase has been applied for): 100,000
-------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period (see
LR3.5.7G): 29,965
-------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 155,679
-------------------------------------
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: Sharesave Scheme
-------------------------------------
Period of return: From: 1 July 2020 To: 31 December 2020
------------------------ ------------ ---- -----------------
Balance of unallotted securities under scheme(s) from previous return: 292,180
-------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the NIL
date of the last
return (if any increase has been applied for):
-------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period (see
LR3.5.7G): 51,829
-------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 240,351
-------------------------------------
Name of contact: Natalie Walter
Telephone number of contact: 01865 783000
---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRBIMITMTMMBIB
(END) Dow Jones Newswires
January 04, 2021 09:09 ET (14:09 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
